In 2002, the research group of Kokkola first reported that HMGB1 was upregulated in the nucleus, cytoplasm, and extracellular environment of the synovial tissue (ST) and synovial cells in patients with RA and experimental arthritis rat models (Kokkola et al. 2002). Here, HMGB1 is linked to arthritic joint disease.